Barclays Maintains Equal-Weight on Cushman & Wakefield, Raises Price Target to $16
Barclays analyst Brendan Lynch maintains Cushman & Wakefield (NYSE:CWK) with a Equal-Weight and raises the price target from $15 to $16.
Stocks · News reference
8-K filing — Cushman & Wakefield Ltd. (CWK)
Filed: 2026-06-15 AccNo: 0001628369-26-000102 Size: 3 MB Item 1.01: Entry into a Material Definitive Agreement Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- edgar
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
UBS Maintains Neutral on Cushman & Wakefield, Lowers Price Target to $15
UBS analyst Alex Kramm maintains Cushman & Wakefield (NYSE:CWK) with a Neutral and lowers the price target from $17 to $15.
Conference Call: Raises FY2026 Sales Guidance from $10.905B-$11.111B to $11.008B-$11.111B vs $11.087B Est
Cushman & Wakefield (NYSE:CWK) Raises FY2026 sales outlook from $10.905 billion-$11.111 billion to $11.008 billion-$11.111 billion vs $11.087 billion estimate.
Cushman & Wakefield Raises FY2026 Adj EPS Guidance from $1.40-$1.46 to $1.44-$1.50 vs $1.46 Est
Cushman & Wakefield (NYSE:CWK) raises FY2026 Adj EPS guidance from $1.40-$1.46 to $1.44-$1.50 vs $1.46 analyst estimate..